iPhone

Home iPhone

No posts to display

- Advertisement -

LATEST INTERVIEWS

Hemispherx Biopharma Announces Significant Progress in its Ampligen Pancreatic Cancer Program...

Hemispherx Provides Quarterly Summary of Rapidly Advancing Oncology Clinical Programs OCALA, Fla., March 13, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc. (NYSE American: HEB) (“Hemispherx”...

RECENT NEWS

381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832